179 related articles for article (PubMed ID: 27659035)
1. Coeliac disease: immunogenicity studies of barley hordein and rye secalin-derived peptides.
Wahab WA; Šuligoj T; Ellis J; Côrtez-Real B; Ciclitira PJ
Int J Exp Pathol; 2016 Aug; 97(4):303-309. PubMed ID: 27659035
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of clinical and immune reactivity to barley and rye ingestion in children with coeliac disease.
Hardy MY; Russell AK; Pizzey C; Jones CM; Watson KA; La Gruta NL; Cameron DJ; Tye-Din JA
Gut; 2020 May; 69(5):830-840. PubMed ID: 31462555
[TBL] [Abstract][Full Text] [Related]
3. Rye gamma-70 and gamma-35 secalins and barley gamma-3 hordein cross-react with omega-5 gliadin, a major allergen in wheat-dependent, exercise-induced anaphylaxis.
Palosuo K; Alenius H; Varjonen E; Kalkkinen N; Reunala T
Clin Exp Allergy; 2001 Mar; 31(3):466-73. PubMed ID: 11260160
[TBL] [Abstract][Full Text] [Related]
4. Degradation of coeliac disease-inducing rye secalin by germinating cereal enzymes: diminishing toxic effects in intestinal epithelial cells.
Stenman SM; Lindfors K; Venäläinen JI; Hautala A; Männistö PT; Garcia-Horsman JA; Kaukovirta-Norja A; Auriola S; Mauriala T; Mäki M; Kaukinen K
Clin Exp Immunol; 2010 Aug; 161(2):242-9. PubMed ID: 20560983
[TBL] [Abstract][Full Text] [Related]
5. Similar Responses of Intestinal T Cells From Untreated Children and Adults With Celiac Disease to Deamidated Gluten Epitopes.
Ráki M; Dahal-Koirala S; Yu H; Korponay-Szabó IR; Gyimesi J; Castillejo G; Jahnsen J; Qiao SW; Sollid LM
Gastroenterology; 2017 Sep; 153(3):787-798.e4. PubMed ID: 28535873
[TBL] [Abstract][Full Text] [Related]
6. Ingestion of oats and barley in patients with celiac disease mobilizes cross-reactive T cells activated by avenin peptides and immuno-dominant hordein peptides.
Hardy MY; Tye-Din JA; Stewart JA; Schmitz F; Dudek NL; Hanchapola I; Purcell AW; Anderson RP
J Autoimmun; 2015 Jan; 56():56-65. PubMed ID: 25457306
[TBL] [Abstract][Full Text] [Related]
7. A bispecific antibody targeting HLA-DQ2.5-gluten peptides potently blocks gluten-specific T cells induced by gluten ingestion in patients with celiac disease.
Hardy MY; Henneken LM; Russell AK; Okura Y; Mizoroki A; Ozono Y; Kobayashi S; Murakami Y; Tye-Din JA
Clin Immunol; 2024 Jul; 264():110259. PubMed ID: 38768856
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the putative immunodominant T cell epitopes in coeliac disease.
Ellis HJ; Pollock EL; Engel W; Fraser JS; Rosen-Bronson S; Wieser H; Ciclitira PJ
Gut; 2003 Feb; 52(2):212-7. PubMed ID: 12524402
[TBL] [Abstract][Full Text] [Related]
9. Barley and rye prolamins induce an mRNA interferon-gamma response in coeliac mucosa.
Bracken SC; Kilmartin C; Wieser H; Jackson J; Feighery C
Aliment Pharmacol Ther; 2006 May; 23(9):1307-14. PubMed ID: 16629935
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease.
Tye-Din JA; Stewart JA; Dromey JA; Beissbarth T; van Heel DA; Tatham A; Henderson K; Mannering SI; Gianfrani C; Jewell DP; Hill AV; McCluskey J; Rossjohn J; Anderson RP
Sci Transl Med; 2010 Jul; 2(41):41ra51. PubMed ID: 20650871
[TBL] [Abstract][Full Text] [Related]
11. Characterization of cereal toxicity for celiac disease patients based on protein homology in grains.
Vader LW; Stepniak DT; Bunnik EM; Kooy YM; de Haan W; Drijfhout JW; Van Veelen PA; Koning F
Gastroenterology; 2003 Oct; 125(4):1105-13. PubMed ID: 14517794
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of enzymatically hydrolyzed prolamins from wheat, rye, and barley as references for the immunochemical quantitation of partially hydrolyzed gluten.
Gessendorfer B; Koehler P; Wieser H
Anal Bioanal Chem; 2009 Nov; 395(6):1721-8. PubMed ID: 19763549
[TBL] [Abstract][Full Text] [Related]
13. Toxic, immunostimulatory and antagonist gluten peptides in celiac disease.
Silano M; Vincentini O; De Vincenzi M
Curr Med Chem; 2009; 16(12):1489-98. PubMed ID: 19355902
[TBL] [Abstract][Full Text] [Related]
14. Celiac disease: how complicated can it get?
Tjon JM; van Bergen J; Koning F
Immunogenetics; 2010 Oct; 62(10):641-51. PubMed ID: 20661732
[TBL] [Abstract][Full Text] [Related]
15. On the immune response to barley in celiac disease: Biased and public T-cell receptor usage to a barley unique and immunodominant gluten epitope.
Dahal-Koirala S; Neumann RS; Jahnsen J; Lundin KEA; Sollid LM
Eur J Immunol; 2020 Feb; 50(2):256-269. PubMed ID: 31628754
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Antibodies for Grain-Specific Gluten Detection.
Sharma GM; Rallabhandi P; Williams KM; Pahlavan A
J Food Sci; 2016 Mar; 81(3):T810-6. PubMed ID: 26878584
[TBL] [Abstract][Full Text] [Related]
17. Coeliac disease: a diverse clinical syndrome caused by intolerance of wheat, barley and rye.
McGough N; Cummings JH
Proc Nutr Soc; 2005 Nov; 64(4):434-50. PubMed ID: 16313685
[TBL] [Abstract][Full Text] [Related]
18. Testing safety of germinated rye sourdough in a celiac disease model based on the adoptive transfer of prolamin-primed memory T cells into lymphopenic mice.
Freitag TL; Loponen J; Messing M; Zevallos V; Andersson LC; Sontag-Strohm T; Saavalainen P; Schuppan D; Salovaara H; Meri S
Am J Physiol Gastrointest Liver Physiol; 2014 Mar; 306(6):G526-34. PubMed ID: 24458020
[TBL] [Abstract][Full Text] [Related]
19. Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls.
Molberg O; Kett K; Scott H; Thorsby E; Sollid LM; Lundin KE
Scand J Immunol; 1997 Sep; 46(3):103-9. PubMed ID: 9315123
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the safety of ancient strains of wheat in coeliac disease reveals heterogeneous small intestinal T cell responses suggestive of coeliac toxicity.
Šuligoj T; Gregorini A; Colomba M; Ellis HJ; Ciclitira PJ
Clin Nutr; 2013 Dec; 32(6):1043-9. PubMed ID: 23465776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
